POSTER 20

Nemolizumab Long-Term Safety and Efficacy up to 104 Weeks in the ARCADIA Open-Label Extension Study in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis

Jonathan I Silverberg, MD; Vivian T. Laquer, Linda Stein-Gold, Diamant Thaçi, Marie Tauber, Marjolein S. De Bruin-Weller, Kim A. Papp, Matthias Augustin, Adam Reich, Matthew J. Zirwas, Soo Yeon Cheong, Anna Ryzhkova, Liliana Ulianov, Christophe Piketty

< Previous Poster | Next Poster >

Poster 20